The medication's mechanism of slowing gastric emptying and reducing appetite commonly leads to gastrointestinal symptoms, particularly during dose initiation and escalation
Active or unstable major depressive disorder (MDD) or other severe psychiatric illnesses (e.g., schizophrenia, bipolar disorder) within the past two years
Although GLP-1RAs are known to have action in the brain, it is possible one mechanism by which GLP-1RAs reduce consumption of ingested drugs such as alcohol is, at least in part, through peripheral mechanisms
That vacuum makes drawing medication difficult, causes air bubbles to form in the liquid, and can even pull the plunger back after you remove the syringe, wasting medication
GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed with Extensively Validated Monoclonal Antibody
Previous rodent studies demonstrated that GLP-1 receptor agonists suppressed the rewarding effects of alcohol and reduced alcohol consumption